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ABSTRACT  We  have  obtained  a  polyclonal  antibody  that  recognizes  a  major  polypeptide 
component of chicken mitotic chromosome scaffolds. This polypeptide migrates in SDS PAGE 
with  Mr  170,000.  Indirect  immunofluorescence  and  subcellular  fractionation  experiments 
confirm  that it is present in  both  mitotic chromosomes and interphase nuclei. Two lines  of 
evidence suggest that this protein is DNA topoisomerase II, an abundant nuclear enzyme that 
controls DNA topological states: anti-scaffold antibody inhibits the strand-passing  activity of 
DNA topoisomerase II; and both anti-scaffold antibody and an independent antibody raised 
against purified  bovine topoisomerase  II  recognize identical partial  proteolysis fragments  of 
the 170,000-mol-wt scaffold  protein in immunoblots.  Our results suggest that topoisomerase 
II  may  be  an  enzyme  that  is  also  a  structural  protein  of  interphase  nuclei  and  mitotic 
chromosomes. 
It has been known for many years that the chromatin fiber of 
both meiotic (1-4) and  mitotic (5) chromosomes is  folded 
into loops. In 1977 and 1978, Laemmli and co-workers (6-8) 
proposed that in mitotic chromosomes these loops are formed 
as a result of interactions between the nucleohistone fiber and 
a subgroup of chromosomal nonhistone proteins. A residual 
structure thought to be enriched in these nonhistone proteins 
was isolated by extraction of nuclease-digested chromosomes 
under conditions that solubilized >90% of the chromosomal 
proteins, including all of the histones (9). Because it retained 
the size and approximate shape of the mitotic chromosome, 
this residual  structure, was  termed the "chromosome scaf- 
fold." More recent studies have shown that the scaffold frac- 
tion is greatly enriched in two high molecular weight polypep- 
tides,  Sc-I  (170,000 mol wt) and Sc-2 (135,000 mol wt; see 
reference 10). 
The existence of a discrete scaffold substructure in intact 
mitotic chromosomes remains a subject of some debate. The 
isolated residual scaffold comprises only 3-4% of the chro- 
mosome mass (10). Therefore, it is not surprising that direct 
inspection of whole mounts (11,  12) or thin sections (13) of 
intact chromosomes does not permit ready visualization of a 
scaffold substructure, although under certain conditions axial 
structures can be seen (14). Localization of scaffold compo- 
nents in intact chromosomes has been forced to wait for the 
availability of anti-scaffold antibodies (15). 
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Results  from  a  number  of laboratories suggestthat  the 
chromatin fiber of interphase chromosomes is also topologi- 
cally constrained  in  loops  (16-22).  ILcorre~t,  this  model 
implies that DNA topoisomerases might be required for the 
termination of replication. For example, the final stages of 
SV40 replication involve production of catenated dimers (23, 
24).  In  the  absence  of nicks,  such  strucures  can  only be 
separated by  a  type II  DNA  topoisomerase. This  class  of 
enzyme changes the linking number of circular DNA mole- 
cules in  steps  of two,  in  an  ATP-dependent reaction that 
proceeds via production of protein-linked double strand DNA 
breaks (recently reviewed in reference 25).  If cellular chro- 
mosomes are constrained in closed loops, then topoisomerase 
1I might play an essential role in termination of replication 
and  for  chromosome segregation.  Analysis  of conditional 
lethal topoisomerase II mutants in the unrelated yeasts Sac- 
charomyces cerevisiae (26) and Schizosaccharomyces pornbe 
(27) confirms that the enzyme is required for chromosome 
segregation,  at least in lower eucaryotes. 
We  describe  experiments performed with  an  antiserum 
against a  170,000-mol-wt chromosome scaffold polypeptide 
from chicken cells. Two independent lines of  evidence suggest 
that this scaffold protein is DNA topoisomerase II. These are 
inhibition  of topoisomerase function by anti-scaffold anti- 
body, and comparison of binding of anti-scaffold and anti- 
topoisomerase II antibodies to partial peptides derived from. 
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anti-topoisomerase  antibody  permits  the  first  quantitative 
analysis of the scaffold isolation procedure. Topoisomerase II 
is recovered at high yield (-70%)  in chromosome scaffolds 
made at either high or low ionic strength.  These results have 
important implications for the control of expression of chro- 
matin domains and for chromosome segregation. 
MATERIALS  AND  METHODS 
Cell  Culture:  MSB-I  cells, the  gift  of H.  Weintraub  (Hutchinson 
Cancer Center, Seattle, WA), were grown in RPMI-1640 (Gibco Laboratories, 
Grand Island, NY) +  5%  Hyclone  fetal calf serum (Sterile Systems, Logan, 
Utah;  later  replaced  with  5%  iron-suplemented  calf serum from the  same 
supplier). Chicken tumor cells, line 249, originally from the laboratory  of M. 
Wigler (Cold Spring Harbor),  were the gift of D. Cleveland (Johns Hopkins 
School of Medicine). These and primary cultures of chick embryo fibroblasts 
(28) were grown in Eagle's minimal essential medium with nonessential amino 
acids (Gibco Laboratories) plus 10% fetal calf serum and 1% chicken serum. 
Production  of Antibody  to  Guinea  Pig  Chicken  Scaffold 
Protein  1:  80 liters of MSB-1 chicken lymphoblastoid cells were grown in 
spinner culture in batches ranging from 1.5-12 liters. Cells were accumulated 
in C-metaphase  by incubation  in the presence of 0.1  ~g/ml colcemid for 12- 
16 h. Chromosomes were isolated by a minor modification  of the polyamine 
method of Lewis and Laemmli  (10). We modified the procedure by replacing 
the 40-ml sucrose gradient with a 16-ml 15-60% gradient over a 10-ml shelf of 
80% sucrose. This procedure gives a chromosome recovery of ~25% (Table I). 
Chromosomes  from each preparation  were frozen on N2(l). 
All solutions  for chromosome and interphase  nuclear  isolations were pre- 
pared  fresh  from  10x  stocks,  and  the  protease  inhibitors  Trasylol  (Mobay 
Chemical Co., FBA Pharmaceuticals,  New York), and phenylmethylsulphonyl 
fluoride (Sigma Chemical  Co., St.  Louis,  MO) were added  to  l0 Kallikrein 
inhibitor units/ml and 0.1  mM, respectively, immediately before use. 
Scaffolds were prepared from 95 mg of  chromosomes  by standard procedures 
using 2 M NaCl to extract the bulk of the chromosomal protein  (9,  14). The 
scaffolds were resuspended  in SDS PAGE sample buffer (10) and electropho- 
resed in two preparative SDS polyacrylamide gels. The gels were washed with 
water to remove SDS and stained with 0.1% Coomassie Blue in  Ix running 
buffer minus SDS (L. Gerace, personal communication).  Bands to be used as 
antigen  were excised, homogenized  in  water  with a  Potter-Elvehjem  motor 
driven homogenizer, and frozen in N2(I). Guinea pigs were injected with ~ 100 
#g of protein in acrylamide plus complete Freund's adjuvant  (Difco Laborato- 
ties,  Inc.,  Detroit,  M1), given a  booster  injection  of-50 ~g (in  incomplete 
Freund's adjuvant) at 30 d, and bled 14 d later by cardiac punture. 
Affinity-eluted antibody  was prepared from preparative nitrocellulose blots 
of SDS polyacrylamide  gels, as described previously (29). 
Production  of Antibody  to Bovine  Topoisomerase  II:  The 
first large scale isolation of topoisomerase  II from a mammalian source, and 
preparation of antibody recognizing the purified enzyme are described in detail 
in  reference  30.  Important steps  in  the  enzyme  purification  included  the 
following: extraction  of nuclei  under conditions  in  which  the  chromosome 
scaffold is sol  ubilized (presence of B-mercaptoethanol [10]); polymin P precip- 
itation of chromatin;  ammonium sulphate precipitation; and chromatography 
on BioRex  70,  hydroxylapatite,  and blue agarose. This  procedure  yielded a 
1,300-fold purification  of the  enzyme,  which  migrated  in SDS PAGE  as a 
doublet  of Mr  125,000 and  140,000 (30). Both  species yielded identical  2- 
dimensional  tryptic maps. A rabbit was injected with a band excised from an 
SDS gel. Serum from this immunized animal  recognizes a single polypeptide 
of Mr  ~  180,000 in  immunoblots of whole  cell lysates from calf, human, 
monkey, hamster (30), and chicken (B. Halligan, unpublished observations). 
Gel Electrophoresis:  Gel recipes were as previously published (10). 
4x sample buffer was 0.125 M trizma base, 0.96 M glycine, 21% glycerol, 2.5% 
SDS, 0.25% bromphenol blue, and 0.5 M 2-mercaptoethanol.  l x sample buffer 
was 0.16 M Tris:HCl, pH 8.8, 16% sucrose, 2.2 mM EDTA, 3.3% SDS, 0.01% 
bromphenol blue, and 22 mM dithiothreitol. 
Immunoblotting:  The protocol  for these experiments  has been de- 
scribed previously (29, 31). 
Immunofluorescence:  Indirectimmunofluorescence  was performed 
I Abbreviations  used in this paper:  CENP-A  and  CENP-B,  human 
centromere proteins of Mr 17,000 and 80,000,  respectively; Sc-1  and 
cSc-l,  human and  chicken  scaffold  protein  1,  respectively;  TCA, 
trichloroacetic acid. 
as previously described (31), except that hepatoma and chick embryo fibroblast 
cultures  were grown  on  polylysine-coated  coverslips.  Before processing  for 
immunofluorescence,  the coverslips were centrifuged at  1,000 g for 2 rain to 
increase adherence  of mitotic  cells. Subsequent  processing was as described 
previously (31). Rhodamine-conjugated  anti-guinea pig IgG was obtained from 
Capp¢l Laboratories (Cochranville, PA). 
Bookkeeping Experiments:  Two methods were used to determine 
the percentage  of total  cellular  chicken  scaffold protein  1 (cSc-1) found in 
chromosomes and nuclei. Procedure a involved spotting solutions containing 
antigen onto nitrocellulose strips and processing these with iodinated protein 
A as for normal immunoblots (31). After drying, the strips were sliced up and 
counted in a gamma counter. In procedure b, aliquots of  samples were subjected 
to SDS PAGE as described previously (10). The proteins were then transferred 
to nitrocellulose paper by electroblotting  (32), and processed in the standard 
way with iodinated  protein A. The blots were used to expose preflashed films 
at  -70°C  (33). Films  were scanned  with  a  densitometer  (Hoefer  Scientific 
Instruments,  San Francisco, CA), and the amount of material in the cSc- 1 band 
determined  by  cutting  out  and  weighing the  peak.  As shown in  Table  1, 
procedures a and b give comparable results. 
The procedure used for chromosome isolation was as follows: 8 h before the 
addition of colcemid to the growing culture, [3H]thymidine was added to 0.12 
#Ci/ml. The colcemid block was as described above. Next morning,  125 ml of 
culture was centrifuged and resuspended to swell in 50 ml of RSB buffer (10 
mM Tris:HCl,  pH 7.4, 10  mM NaC1, 5 mM MgCI2). After 5 min at room 
temperature (during which time the mitotic index was measured), the cells were 
centrifuged at 800 g for 3 min.  The swollen cell pellet was vigorously resus- 
pended in  10 ml lysis buffer (15 mM Tris:HCl, pH 7.4, 2 mM K-EDTA, 80 
mM KCI, 0.2 mM Spermine, 0.5 mM Spermidine, 0.1% digitonin  [10]), and 
the cells disrupted with 10 strokes of a Dounce homogenizer. 50 #1 of homog- 
enate was removed and stored at 4°C for subsequent trichloroacetic acid (TCA) 
precipitation.  Two 0.5-ml aliquots  of lysate were removed and processed for 
electrophoresis as follows: CaCI2 was added to 3 mM and micrococcal nuclease 
(Worthington  Biochemical Corp.,  Freehold,  N  J) to 40  /zg,,'ml. The digestion 
was allowed to proceed 20 rain at 4°C and then terminated  in one of  two ways. 
To one aliquot  was added  % volume of 4x SDS PAGE sample buffer. This 
aliquot  was  then  extensively  sonicated  and  boiled,  yielding  a  sample  for 
determination  of total antigen. After nuclease digestion, the other aliquot was 
centrifuged at  16,000 g for 10 rain and then resuspended in 0.5  ml  Ix SDS 
PAGE sample buffer. This was then sonicated and boiled, yielding the sample 
for determination  of total insoluble antigen. During the processing of the above 
samples, the rest of the homogenate  was processed for chromosome isolation 
as described  by Lewis and Laemmli  (10). The final chromosome pellet was 
resuspended  in  0.5  ml  of 5  mM  Tris:HCl,  pH  7.4,  2  mM  KC1, 0.25 mM 
spermidine,  0.1% digitonin  (10), The chromosomes were then  processed for 
determination  of 3H and total insoluble antigen as described above. 
The chromosome yield was calculated as the percent of acid-insoluble 3H 
recovered, taking into account the mitotic index, since this procedure separates 
chromosomes  from nuclei. The TCA precipitation was performed by standard 
methods, with nucleic acid being precipitated by 10% TCA in the presence of 
1.5% Na-pyrophosphate  and 0.1% bovine  serum albumin (BSA) as carder. 
Precipitates, collected on GF/C (Whatman Chemical Separation  Inc., Clifton, 
N  J) filters were counted in Aquasol-2 after drying. The final yield of cSc-l was 
measured by either procedure a or b as described above. The final yields were 
normalized by taking into account the chromosome yield calculated above, the 
relative amounts of original culture loaded per lane (0.15 ml for homogenate, 
3.9 ml for chromosomes), and (where applicable) the width of the gel lanes. 
The amount of cSc-I in interphase  nuclei was calculated as follows: Cells 
were grown  overnight  in  the  presence  of [3H]thymidine  as  above,  but  no 
colcemid was added.  Next morning,  cells (50-ml culture) were centrifuged at 
800 g for 3 min and resuspended for hypotonic swelling in RSB buffer (see two 
paragraphs above) for 5 min at room temperature.  They were then centrifuged 
at 800 g for 3 rain and resuspended in 4 ml lysis buffer (same as chromosome 
lysis buffer above,  but plus 20%  percoll [modified from  reference 34]). Cell 
disruption  was accomplished by vigorous Dounce homogenization  (20x).  An 
aliquot  was taken  as above for TCA precipitation,  0.5  ml removed  for mea- 
surement of antigen, and the rest of the lysate centrifuged at 250 g for 5 min. 
The supernatant was removed  by aspiration,  and the  pellet of nuclei  resus- 
pended  in 4 ml lysis buffer. After a second centrifugation,  the  nuclear pellet 
was resuspended  in a volume equal to that of the original homogenate,  SDS 
added to 0.1%, the sample lightly sonicated, an aliquot taken for TCA precip- 
itation, and the remainder  processed for detection  of antigen by procedure  a 
described above. 
Enzyme Assays:  Mitotic chromosomes  were prepared from 500 ml of 
colcemid-arrested  MSB-I  chicken  lymphoblastoid  cells by gentle differential 
centrifugation  (15). Topoisomerase  II extracts were prepared  from the chro- 
mosomes by the  method  of Miller et al. (35). Extracts were incubated  with 
EARNSHAW  ET  At.  Topoisomerasell  1707 antisera (all used at a dilution of 1:50) for 1 h at 4°C with gentle agitation. 
Immune complexes  were adsorbed by addition of fixed Staphylococcus aureus 
to ~0.6% (wt/vol). This suspension was incubated for 1  h at 4"C with agitation, 
and the immune complexes  subsequently  removed  by centrifugation  at 16,000 
g for 5 min. Assay  conditions for topoisomerase l (relaxation of supercoiled 
pBR322 DNA [36])  and topoisomerase  II (unknotting  of phage P4 DNA [37]) 
were as previously  described, except that the incubation was done at 37"C for 
2h. 
RESULTS 
Production of Antibodies to a Polypeptide from 
Chicken Chromosome Scaffolds 
Fig.  1 shows the protein composition of mitotic chromo- 
somes  and  chromosome  scaffolds  isolated  from  colcemid- 
blocked chicken cells (line  MSB-1). Chromosomes (Fig.  1 b) 
were isolated by the polyamine method of  Lewis and Laemmli 
(10). Nonhistone scaffolds isolated from these chromosomes 
after  digestion  with  micrococcal  nuclease  and  subsequent 
extraction with 2 M  NaCl (9) are shown in Fig.  1 c. Chromo- 
somal proteins solubilized by the extraction are shown in Fig. 
1 d.  The protein  composition of chicken chromosome scaf- 
folds is similar to that  of human  scaffolds, as described by 
Lewis and Laemmli (10). Scaffolds of identical protein com- 
position  were  obtained  if a  low  ionic  strength  polyanion 
extraction procedure (9,  14) was used in place of 2 M  NaC1 
(data not shown). 
A  guinea  pig  immunized  with  a  high  molecular  weight 
polypeptide  from chicken  chromosome scaffolds (indicated 
by arrows in Fig.  1) produced antibodies that bind to a single 
band (Mr  170,000) on nitrocellulose blots of an SDS PAGE 
of whole cells (Fig. 2 b). This is the antigen we refer to as cSc- 
1. These antibodies  bind to cSc-1  and a  number of smaller 
FIGURE  1  SD5  PAGE of  chicken 
chromosomes and nonhistone scaf- 
folds  isolated  from  them.  Lane a, 
marker proteins myosin (200 kD), ~- 
galactosidase (116 kD), phosphoryl- 
ase b (95 kD),  bovine serum albu- 
min (68 kD), catalase (60 kD), actin 
(43 kD), aldolase (40 kD), carbonic 
anhydrase (29 kD), and beta-lacto- 
globulin (18.4 kD). Lane b, isolated 
chromosomes.  Lane  c,  chromo- 
some  scaffolds  isolated  after  2  M 
NaCI  treatment.  Lane  d,  proteins 
extracted  from  chromosomes  by 
the 2 M  NaCl treatment.  The pro- 
teins  were  electrophoresed  in  a 
10%  polyacrylamide gel  (10) and 
visualized by staining with Coomas- 
sie  Blue.  The  profile  of  scaffolds 
isolated  after extraction with  dex- 
tran  sulfate  and  heparin  (9)  was 
identical to that in lane c; however, 
patterns  of the  proteins extracted 
by the polyanion procedure were 
difficult to obtain as the polyanions 
interfere with  the  mobility of the 
proteins  in  the  gel  lane.  Several 
prominent scaffold  proteins are in- 
dicated  by  dots  between lanes  b 
and c. Major extracted  proteins are 
shown  by dots next to lane d. The 
position  of  cSc-1  is  indicated  by 
arrows, 
FIGURE 2  Immunoblots  of  cellular  and  chromosomal  proteins 
probed with anti-cSc-1.  Bound antibody was detected by autora- 
diography after  reaction with  12Sl-protein  A.  Lane a, mitotic cells 
centrifuged and resuspended  in boiling SDS PAGE sample buffer; 
Coomassie Blue stain. Lane b,  parallel gel lane probed with anti- 
cSc-1.  In  all  subsequent  lanes the  antigen  mixture  came  from 
isolated  mitotic chromosomes and the antibodies used to  probe 
the blots were as follows: (lane c) whole serum anti-cSc-1;  (lane d) 
preimmune serum; (lane e) anti-cSc-1  affinity eluted from the cSc- 
1 band of a preparative immunoblot (indicated to the right of lane 
f and  marked m); and (lane f) anti-fragments affinity eluted from 
the indicated region (marked f) of a preparative immunoblot. Whole 
serum  was  used at  a dilution of  1:500. Affinity-eluted antibody 
fractions  were used at a dilution of 1:20. For a Coomassie Blue- 
stained view of the antigen mixtures in lanes c-f see Fig. 1  b. 
peptides present in isolated chicken chromosomes (Fig. 2 c). 
Preimmune serum did not bind to any chromosomal proteins 
(Fig. 2 d). The smaller peptides appear when cells are homog- 
enized in the presence of detergent, and co-purify with chro- 
mosomes.  Antibody fractions  that  had  been  affinity-eluted 
from either cSc-1 or from the smaller peptides gave identical 
patterns  when  used to  reprobe  blots  of total  chromosomal 
proteins (Fig. 2, e and f). This, together with the observation 
of a single antigenic species in boiled whole cell extracts (Fig. 
2 b),  suggests that the  smaller  peptides  are  proteolytic frag- 
ments derived from cSc- 1. 
Evidence  That the Scaffold Protein cSc-1 Is 
Topoisomerase II 
Both cSc-1  and topoisomerase II isolated from a  number 
of species, migrate in SDS PAGE with Mr  170,000 (30,  35). 
The  following  experiments  suggest  that  cSc-1  is,  in  fact, 
topoisomerase II. 
First, both guinea pig anti-cSc-1 and rabbit anti-topoisom- 
erase  II (prepared  against  enzyme purified  to  homogeneity 
from calf thymus [30]) bind to identical ladders of polypep- 
tides on immunoblots of chicken chromosomes and scaffolds 
(Fig.  3,  b  and  c).  The  major immunoreactive polypeptides 
that  migrate  ahead  of  cSc-1  have  apparent  Mr  126,000, 
117,000,  106,000,  98,000,  91,000,  and  81,000,  These  are 
presumed  to  be  proteolytic  fragments  of cSc-I  (preceding 
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tional bands (corresponding to smaller fragments) are recog- 
nized by both sera.  Neither preimmune serum (Fig.  3 a) nor 
guinea pig  sera raised against  other high  molecular weight 
chromosome scaffold components bind to any of these bands 
(W.  C.  Earnshaw,  unpublished observations). We therefore 
conclude that both antisera recognize specific epitopes that 
FIGURE  3  Topoisomerase II is found in chicken chromosome scaf- 
folds. Chromosomes and scaffolds were electrophoresed in parallel 
lanes of an  SDS  polyacrylamide gel, transferred to  nitrocellulose, 
and  probed  with  the  following  sera:  (a)  guinea  pig  preimmune 
serum; (b) guinea pig anti-cSc-1;  (c)  rabbit anti-topoisomerase II. 
Bound antibody was detected by incubation of the blot with ~2Sl- 
protein A,  followed by autoradiography. The figure shows immu- 
noblots of isolated chromosomes (c) and chromosome scaffolds (s) 
prepared by extraction of nuclease-digested chromosomes with a 
2 M  NaCI lysis mix. The positions of the fragments are indicated by 
arrowheads to the  right of c.  The  core  histones  migrate with  the 
dye front in this 7.5% acrylamide gel. frog., fragments. 
are present on intact cSc-I and on various fragments derived 
from it. 
The results of Fig.  3 c indicate that topoisomerase II is a 
component of chicken mitotic chromosomes and  chromo- 
some scaffolds.  Similar results have been obtained for HeLa 
chromosomes and scaffolds using a similar antibody (W. C. 
Earnshaw, B. Halligan, and L. F. Liu, unpublished observa- 
tions). Comparison of Fig.  3, b and c, suggests strongly that 
the scaffold antigen cSc- 1 is topoisomerase II. While our data 
do not establish unambiguously that topoisomerase II is the 
only 170,000-mol-wt antigen present in scaffolds,  this is the 
most likely interpretation of the results. 
This interpretation of our results is supported by fraction- 
ation of the proteins of isolated chromosomes by hydroxyl- 
apatite  chromatography in  the  presence of SDS  (data  not 
shown). This method has been shown to effectively resolve 
high molecular weight structural proteins (38). Column frac- 
tions were analysed by SDS PAGE and immunoblotting with 
guinea pig anti-cSc-1  and rabbit anti-topoisomerase II. Both 
antibodies gave identical patterns, with 170,000-mol-wt poly- 
peptide eluting at 0.52 M  NaPO4,  0.1%  SDS,  and the frag- 
ments eluting somewhat earlier (0.46 M NaPO4, 0.1% SDS). 
Most  polypeptides elute  from  hydroxylapatite by  ~0.4  M 
NaPO, (39), and this late elution of topoisomerase II, which 
was noted previously (30),  was interpreted as an indication 
that the polypeptide may be rich in hydrophobic residues. 
The identity of cSc-1  as topoisomerase II has been sup- 
ported by showing that both topoisomerases I and II can be 
extracted in active form from chicken chromosomes (Fig. 4) 
and that antibodies to cSc-1 can absorb the topoisomerase 1I 
activity from the extracts (Fig. 4, left; compare lanes E through 
H with lanes A through D, respectively). Note that topoisom- 
erase II is extracted from chromosomes under conditions in 
which the chromosome scaffold has been shown to fall apart 
(presence of 2-mercaptoethanol [ 10]). Preimmune serum had 
no effect on the activity of the enzyme (Figure 4A; compare 
lanes I  through L with lanes A through D, respectively), and 
neither preimmune serum nor anti-cSc-1  had any effect on 
the activity of topoisomerase I in these extracts (Fig, 4, right). 
Identical results were obtained if  the rabbit anti-topoisomerase 
II antiserum was substituted for anti-cSc-1  (data not shown). 
FIGURE  4  Effect  of  various  antisera  on  the  activity  of  topoisomerases  I  and  II  in  extracts  prepared  from  isolated  mitotic 
chromosomes. Extracts were exposed to (lanes A-D)  no antibody, (lanes E-H) anti-cSc-1, and (lanes I-L) preimmune serum. An 
assay for topoisomerase II  is shown on the left. The results of a parallel assay for topoisomerase I are shown on the right. The 
amount of extract in each reaction mixture (20 pl volume) is as follows: 1 /~1 for samples in lanes A,  E, and/; 0.25 u,I for samples 
in lanes B, F, and J; 0.0625/A  for samples in lanes C, G, and K; and 0~0156 pl for samples in lanes D,  H, and L  The smear in the 
left  panel  represents  the  heterogeneously  knotted  P4  DNA  used  to  assay  topoisomerase  II  (37).  The  migration  of  form  I 
(supercoiled), form f~ (relaxed), and form  Ill (linear) pBR322  DNA used in the assay for topoisomerase P  (36) is indicated to the 
right of the right-hand panel. 
EARNSHAW ET AL,  Topoisornerase  II  1709 FIGURE 5  Indirect immunofluorescence using whole serum and affinity-eluted anti-cSc-1.  The cells used for a-c were line 249, 
a transformed  chicken cell line. d-f show a parallel  experiment performed using an  untransformed  primary  culture of chick 
embryo fibroblasts, a and d are phase-contrast images, b and e show staining of the DNA using DAPI, a nonintercalating  dye that 
is brightly fluorescent when bound to DNA (58). c and f present the localization of topoisomerase II in these same cells using 
anti-cSc-1  (c, whole serum; f, affinity-eluted anti-cSc-1) and rhodamine-conjugated  anti-guinea pig second antibody. Bar, 10 pm. 
Therefore, we conclude that anti-cSc-1  recognizes functional 
topoisomerase II. 
Localization of Topoisomerase  II in Mitotic and 
Interphase Cells: Immunofluorescence Results 
Topoisomerase II was localized in detergent extracted cells 
by indirect immunofluorescence using anti-cSc-1 (Fig. 5). The 
enzyme was  found in  nuclei and  mitotic chromosomes of 
both transformed cell lines (Fig.  5, a-c) and untransformed 
primary cultures (Fig.  5, d-f).  Little or no antigen was de- 
tected in the cytoplasm. Similar results were obtained with 
cells  fixed with organic solvents. All mitotic chromosomes 
were found to label intensely (see reference 15 for details), but 
the staining of interphase nuclei varied considerably. Many 
nuclei exhibited bright punctate fluorescence, while others 
stained only weakly. 
Using  MSB-1  cells  separated  into  Gt,  S,  and  G2  +  M 
populations by a fluorescence-activated cell sorter, we found 
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that virtually all cells that fail to stain with anti-cSc-1  have a 
Gt DNA content. Negative cells represent the following per- 
centages of the cells in each cell cycle phase: GI,  14% (71/ 
494); S, 2% (13/488); and G2 + M, 0% (0/297). Labeled cells 
from different cell cycle phases were indistinguishable with 
regard to the distribution of fluorescent antibody binding. 
We  have considered two  possible  explanations for these 
results.  The antigen may be masked (or degraded) during a 
brief portion of Gt.  Alternatively, cells  that  are  no longer 
cycling (and that would have a  G~  DNA content) may no 
longer contain topoisomerase II. 
Independent confirmation that topoisomerase II is found 
in mitotic chromosomes is presented in Fig.  6.  This ~,figure 
shows  chromosomes from  chicken mitotic  cells  that  were 
gently disrupted by centrifugation onto glass coverslips (for 
methods, see reference 15). The coverslips were then stained 
with preimmune serum (Fig. 6 b) or rabbit anti-topoisomerase 
II (Fig.  6d).  Fig.  6, a  and c, show the distribution of chro- 
mosomal DNA (stained with 4',6-diamidino-2-phenylindole 
dihydrochloride) in the corresponding fields. FIGURE  6  Identification  of  topoisomerase II  in  mitotic  chromosomes.  Chicken  mitotic  cells  were  hypotonically swollen  and 
centrifuged onto coverslips (15). a and c show the distribution of DNA (stained with 4',6-diamidino-2-phenylindole dihydrochlo- 
ride)  in  these chromosomes,  b  and  d  show the  immunofluorescence obtained with  (b) rabbit  preimmune serum  and  (d) anti- 
topoisomerase II from this animal. Bar, 10 #m. 
TABLE  I 
Data 
Normalized recovery of topoisomerase I1" 
Fraction  Recovery of structure  Total*  Sedimentable  j  N m  Procedure 
Interphase nuclei  65 -+ 11%  91  +  15%  ND  20  a 
Chromosomes  16 ___ 8%  56 _  21%  ND  4  a 
Chromosomes  28 __ 9%  64 +  21%  87 +  35%  20  b 
ND,  not, determined. 
* Expressed as 100 x  (recovery of topoisomerase II)/(recovery of structure). 
* Calculated as 100 x  (tllch,om,.uJtlltoO,  where tll~h,om,.uc is the amount of topoisomerase antigen in chromosomes  (tilth,ore)  or nuclei (tll.u~)  isolated  from a known 
culture volume and tlltot is the amount of topoisomerase II in an equivalent volume of the crude whole-cell homogenate from which the structures  had been 
isolated. 
t Calculated as  100 x  (tllch~m,.,,Jtll~),  where tll~  is the amount of topoisomerase antigen that could  be pelleted from an equivalent volume of whole-cell 
homogenate by centrifugation at 16,000 g for 10 min. 
'  Number of independent determinations. 
Localization of Topoisomerase II in Mitotic and 
Interphase Cells: Cell Fractionation Experiments 
Quantitative cell fractionation and immunoassays (Table I) 
support the conclusions ofimmunofluorescence  experiments. 
Interphase nuclei, isolated by a simple differential centrifuga- 
tion procedure, in the presence of detergent, contain 91% of 
the total immunoreactive topoisomerase II present in the cells. 
Therefore, neither immunofluorescence nor this cell fraction- 
ation experiment provide evidence for the existence of a pool 
of cytoplasmic topoisomerase II in interphase cells. 
Similarly, the bulk of topoisomerase II from mitotic cells is 
found in  isolated chromosomes. When a  total cell homog- 
enate from mitotic cells was centrifuged at  16,000 g  for 10 
min  (to pellet all  chromosomes and  nuclei),  ~70%  of the 
topoisomerase II (the sedimentable antigen) was recovered in 
the  pellet.  When  chromosomes were isolated from  similar 
homogenates, 87%  of the  sedimentable antigen co-purified 
with the chromosomes through sucrose and Percoll gradients. 
This corresponds to ~60% of the total cellular pool of topoi- 
somerase II. 
Not all topoisomerase II from mitotic cells co-purifies with 
chromosomes. About 30% of  the antigen is apparently soluble 
in total cell  homogenates. We have considered three likely 
explanations for this result. First, it is possible that the soluble 
antigen is proteolysed. However SDS PAGE/immunoblotting 
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polypeptide to  smaller fragments is essentially identical for 
both soluble and  sedimentable antigen.  Alternatively, there 
may be two pools of enzyme in mitotic cells. While it is clear 
that  most enzyme is associated with mitotic chromosomes, 
the remainder may either be soluble (and completely extracted 
from cells by our immunofluorescence procedure), or it may 
be reversibly bound to chromosomes. Finally, it is possible 
that the soluble antigen is derived from chromosomes dam- 
aged  by  the  homogenization,  or  from  microchromosomes 
which may not sediment under the centrifugation conditions 
used. 
FIGURE  7  Chromosome scaffolds reacted with affinity-eluted anti- 
topoisomerase II (undiluted). The views shown are: (a) phase con- 
trast;  (b)  indirect  immunofluorescence using  rhodamine-coupled 
anti-guinea pig  IgG. Scaffolds  were  produced  by  extraction of 
nuclease-digested chromosomes with dextran sulfate/heparin (14). 
After  the  extraction,  aliquots were  sedimented onto  coverslips 
through  a  cushion  of  0.1  M  sucrose  in  extraction  buffer.  The 
remainder of the material was analyzed by SDS PAGE to confirm 
that  the  extraction  had  proceeded  normally. A  parallel control 
experiment with preimmune serum is not shown since both phase- 
contrast and fluorescence microscopy lacked an,/visible structures. 
The paired and single dots are scaffolds of chicken microchromo- 
somes. Note that  of the scaffolds from larger chromosomes,  only 
those that impact the coverslip en face will present a classical paired 
chromatid appearance. Bar, 10 ~m. 
FIGURE  8  Immunoblotting  of 
proteins  of  isolated  chromo- 
somes,  chromosome  scaffolds, 
and  extracted  fractions  using 
anti-topoisomerase  II.  In  all 
cases  the  samples  were  pre- 
pared as for those in Fig. 1, elec- 
trophoresed in a 7.5% SDS pol- 
yacrylamide gel,  and  immuno- 
blotted using  whole serum  di- 
luted  1:500. The samples elec- 
trophoresed in  the  lanes were 
(a)  chromosomes,  (b)  scaffolds 
isolated  after extraction of nu- 
clease  digested  chromosomes 
with dextran sulfate/heparin,  (c) 
proteins released  by  the  poly- 
anion  extraction,  (d)  scaffolds 
isolated  after  extraction of nu- 
clease  digested  chromosomes 
with 2 M  NaCI, and (e) proteins 
released  by the 2  M  NaCI ex- 
traction. The position of cSc-1 is 
indicated. 
Recovery of Topoisomerase  II in Isolated 
Chromosome Scaffolds with High Yield 
Indirect immunofluorescence confirms that topoisomerase 
II is found in  structures with the  morphology expected for 
chicken mitotic chromosome scaffolds (Fig.  7). Even though 
isolated scaffolds are  not  visible under phase contrast (Fig. 
7 a), they are easily visualized using the specific antibody (Fig. 
7 b). In addition to a  number of chromosome-shaped struc- 
tures, Fig. 7 b also contains numerous single and paired fluo- 
rescent dots.  These are the  scaffolds of microchromosomes 
(minute chromosomes that are a  natural component of the 
chicken karyotype and are present in about 60 copies per cell 
[40]). 
At least 70%  of the chromosomal topoisomerase II is re- 
covered in scaffold fractions prepared by extracting isolated 
chromosomes at  either  low  or  high  ionic  strength.  In  the 
experiment shown in Fig. 8, equal starting volumes of isolated 
chromosomes (Fig.  8 a), scaffolds (Fig.  8, b and d) and pro- 
teins solubilized during the extraction (Fig.  8, c and e) were 
electrophoresed and analysed by immunoblotting. The recov- 
ery of topoisomerase II in scaffolds prepared using the 2 M 
NaC1 extraction (Fig.  8,  b  and  c) was virtually identical to 
that found using the low salt dextran sulphate:heparin extrac- 
tion (Fig.  8, d and e). In four independent experiments, the 
average values obtained were the following:  NaC1 scaffolds, 
72  __.  10%  recovery; and  polyanion  scaffolds,  72  __.  14% 
recovery. The 72% figure is a minimum value for the fraction 
of topoisomerase  II  associated  with  scaffolds,  since  some 
fragmentation of scaffolds occurs during the extraction pro- 
cedure (W.  C.  Earnshaw and  U.  K.  Laemmli, unpublished 
observations).  In  addition,  scaffolds of microchromosomes 
may be too small to sediment under the conditions we have 
used. 
DISCUSSION 
Until recently, the literature on eucaryotic topoisomerase lI 
has dealt  largely with  in  vitro studies,  and  little  is  known 
about the function of the enzyme in living cells (reviewed in 
reference 25).  The bacterial enzyme (DNA gyrase) has been 
implicated in replication, transcription, repair, and recombi- 
nation (reviewed in references 41, 42) and it has been assumed 
that the eucaryotic enzyme is required for similar functions. 
Recent isolation of conditional lethal topoisomerase II mu- 
tants in yeast confirms that the enzyme is essential for cell 
growth (26,  27).  Furthermore, at least in synchronized cells, 
the phenotypic block appears to affect chromosome segrega- 
tion. Involvement oftopoisomerase II in segregation had been 
predicted earlier (23,  24),  based on detailed analysis of the 
terminal stages of SV40 replication. 
Analysis of the yeast mutants suggests  that topoisomerase 
II has a  physiological role in regulating events at the  chro- 
mosomal level.  Our observation that the enzyme is a struc- 
tural component of the mitotic chromosome scaffold suggests 
that specific ultrastructural interactions might contribute sig- 
nificantly to regulation of the activity of topoisomerase II in 
vivo. 
Topoisomerase  II Is a Structural Component of 
Chicken Chromosome Scaffolds 
Published data on the composition of mitotic chromosome 
scaffolds indicate that the structures are composed of a well 
defined subset of chromosomal proteins (10,  14). The basis 
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preparation is currently unknown, although one likely expla- 
nation is that the proteins exhibit some association within 
intact chromosomes. Whether or not these proteins are assem- 
bled into a discrete scaffold substructure remains the subject 
of ongoing investigation. 
Because chromosome scaffolds contain the most insoluble 
proteins found associated with  mitotic chromosomes, it  is 
necessary to demonstrate that specific proteins that appear in 
scaffolds  are bona  fide chromosomal components and  not 
insoluble contaminants of the scaffold fraction. Four inde- 
pendent arguments suggest that the association of topoisom- 
erase II with mitotic chromosomes and scaffolds results from 
high affinity interactions rather than random precipitation or 
adventitious binding. 
(a) Enzyme assays, immunofluorescence, and cell fraction- 
ation all indicate that topoisomerase I1 is an integral compo- 
nent of mitotic chromosomes. We  find no evidence for a 
substantial cytoplasmic pool of  the enzyme in interphase cells. 
It has been suggested that certain scaffold components might 
be insoluble fragments of cytoskeleton that contaminate iso- 
lated chromosome fractions (10). Clearly, this objection does 
not apply to topoisomerase II. 
As expected, the enzyme occurs in interphase nuclei. Sur- 
prisingly,  however, it is greatly reduced or absent from some 
cells. These cells were shown to have a Gj DNA content, and 
may no longer be cycling.  That topoisomerase II  is  found 
only in  cycling cells is  supported by the  observation that 
enzyme activity is difficult to detect in normal rat liver (43; 
Halligan  and  Liu,  unpublished),  but  is  readily detected  in 
regenerating liver (43). 
(b) Results of high resolution localization of topoisomerase 
II in intact chromosomes suggest that the enzyme is located 
at the base of the radial chromatin loops (15).  Both immu- 
nofluorescence  and immunoelectron microscopy indicate that 
the enzyme occupies a  restricted region around the axis of 
swollen chromosomes. In addition, structural alterations re- 
suiting from treatment of swollen chromosomes in solution 
with anti-topoisomerase II support the conclusion that  the 
enzyme is not found in the radial chromatin loops. 
(c) The enzyme is found in chromosome scaffolds prepared 
in two different ways.  These involve extraction of chromo- 
somes with 2 M NaCI or with a low ionic strength polyanion 
mixture.  The conductivity of the latter is equivalent to  20 
mM NaC1 (14).  Evidence presented elsewhere indicates that 
these two methods extract chromosomal proteins by different 
mechanisms. The polyanion extraction is inhibited by as little 
as 12 mM added NaCI (14).  In addition, the morphology of 
scaffolds produced by these two procedures is extremely dif- 
ferent (14).  Despite these differences, the protein composi- 
tions of  both types of  scaffolds are similar (10), and the percent 
recovery of topoisomerase II is identical for both procedures. 
(d) Topoisomerase II  is recovered in  scaffolds with  high 
yield. In fact, 70% of the enzyme present in isolated meta- 
phase chromosomes is recovered in scaffolds. Therefore, iso- 
lation of the scaffold is an efficient procedure. Some of the 
material lost from scaffolds is presumably lost due to frag- 
mentation of the structures during extraction, and as a result, 
the 70%  figure for topoisomerase II is probably an underes- 
timate. 
Our interpretation of  the above results is that topoisomerase 
II is a bona fide structural component of mitotic chromosome 
scaffolds. Counter arguments that the enzyme occurs in scaf- 
folds as a result of adventitious sticking (13, 44) are difficult 
to reconcile with our observation that the enzyme is recovered 
with high yield in  scaffolds prepared at both low and  high 
ionic strength (points c and d above). 
Comparison with Other Scaffold Proteins 
Comparison of the above results with those obtained for 
other scaffold proteins is difficult, since this report describes 
the first experimentally raised serum  to  recognize a  major 
scaffold protein.  One  unrelated  scaffold protein  has  been 
characterized in some detail, however, This is CENP-B, an 
80,000-mol-wt human centromere protein that is detected by 
autoimmune sera from certain patients with rheumatic dis- 
eases (29, 31).  Both electron microscopy (14) and a  combi- 
nation  of immunoblotting and  immunofluorescence using 
the autoimmune sera (3 l) indicate that centromere compo- 
nents are retained in chromosome scaffolds prepared by our 
methods. Analysis of immunoblots similar to those shown in 
Fig. 8 indicates that 61  _+  13% of the CENP-B is retained in 
scaffolds (W. C. Earnshaw, unpublished observations). 
The same immunoblots show that CENP-A (a related cen- 
tromere protein of_Mr 17,000 [29]) is completely solubilized 
during the scaffold extraction procedure (3 l). CENP-A and 
CENP-B share antigenic determinants (29). Therefore, struc- 
turally related proteins localized in  close proximity in  the 
chromosome may differ greatly in their binding to the chro- 
mosome scaffold.  This is  further evidence that the protein 
composition of the scaffold fraction is determined by specific 
interactions. 
IS Human Sc-1 Topoisomerase  I1? 
When  the  protein  composition  of human  chromosome 
scaffolds was analyzed in detail, the structures were found to 
be significantly enriched in two polypeptide species, Sc-1 (Mr 
170,000) and Sc-2 (M, 135,000 [10, 14]). We have now shown 
that a chicken scaffold protein of  Mr 170,000 is topoisomerase 
II.  However, recent evidence suggests  that  human  Sc-I  is 
composed of at least three co-migrating polypeptides. 
(a) Both chicken and human (W. C. Earnshaw, B. Halligan, 
M. M. Heck, and L. F. Liu, unpublished observations) chro- 
mosome scaffolds contain topoisomerase I1 as demonstrated 
by immunoblotting and immunofluorescence. 
(b)  A  second  polypeptide of Mr  170,000  in  humans  is 
antigenically related to a chicken chromosomal antigen of Mr 
135,000  (M.  M.  Heck and W.  C.  Earnshaw, manuscript in 
preparation). This antigen is not topoisomerase I1. 
(c) A third human chromosomal polypeptide of  Mr 170,000, 
recognized by a human autoimmune serum (W. C. Earnshaw 
and N.  F.  Rothfield, unpublished observations) is antigeni- 
cally related to a chicken chromosome protein of  Mr 160,000. 
This species  is also apparently not topoisomerase II, and is 
not recognized by our anti-cSc-1  serum. 
These results suggest  that human  Sc-1 is composed of a 
mixture of polypeptides. Therefore any functional analysis of 
this species that relies solely on one-dimensional SDS PAGE 
must be interpreted with caution. 
Implications for the Organization of 
Interphase  Nuclei 
While loop models provide a  convenient framework for 
understanding  the  structure  of mitotic  chromosomes and 
interphase nuclei, most interest on chromatin domains centers 
on  interphase,  where the genome is  physiologically active, 
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acterized.  Data consistent with the  existence  of chromatin 
loop  domains  in  interphase  cells  has  been  obtained  using 
several different techniques (16-22). These domains are sim- 
ilar in size to the radial loops observed directly in swollen and 
dehistonized mitotic chromosomes (7,  14, 45). 
Our  data  suggest  that  the  cell  might  use  an  enzymatic 
mechanism to control the topology of these loop domains. 
Previous workers have pointed out correlations between the 
size of loops in  interphase chromatin and the size of both 
replicons  and  regions  of intermediate  DNase  I  sensitivity 
flanking actively transcribed genes (20,  46-48).  The impor- 
tance of loop structures in transcription has long been known 
for the case of lampbrush chromosomes (49,  50).  More re- 
cently, it was proposed that promoters might be activated or 
repressed through alterations in superhelicity (51, 52). Super- 
helicity might be controlled by alterations in the secondary 
structure of the DNA (53,  54), transient dissociation of nu- 
cleosomes from control regions (55), or by the action of an 
ATP-requiring eucaryotic DNA gyrase (as suggested by recent 
drug studies [56]). Although isolated eucaryotic type II topo- 
isomerases lack gyrase activity (25), the logical candidate for 
the putative gyrase in vivo remains topoisomerase II. 
One role for topoisomerase II in vivo has been shown to be 
resolution of catenated loops that result from replication of 
closed circular DNA molecules. The enzyme is required for 
chromosome  segregation  in  procaryotes  (Escherichia  coli 
[57]), viruses (SV40 [23, 24]), and lower eucaryotes (S. cere- 
visiae [26]; S. pombe [27]). 
The radial loop model of chromosome structure proposed 
that each chromosome consists of loops that are topologically 
fixed due to binding of scaffold proteins (6, 7,  10, 45).  One 
efficient way of regulating the segregation of these domains 
after replication would be to make the enzyme required for 
decatenation (topoisomerase II)  part  of the  framework re- 
sponsible  for  establishment  and  maintenance  of the  loop 
structure. Therefore, topoisomerase II would be expected to 
be a  component of the insoluble "nuclear matrix"  fraction 
prepared from interphase cells, That this is indeed the case 
has been demonstrated by the experiments of Berrios et al. 
(59) using antibody recognizing the Drosophila enzyme, and 
also by experiments from this laboratory using the rabbit anti- 
topoisomerase II antibody discussed  above and  nuclei pre- 
pared  from Drosophila and  rat  (Halligan,  B.,  D.  Small,  B. 
Vogelstein, T.-S. Hsieh, and L. F. Liu, manuscript submitted 
for publication). 
If topoisomerase II were part of the structural framework 
responsible  for the  loop  organization of the  chromatin of 
mitotic chromosomes, the enzyme would be expected to be 
concentrated at the base of the radial chromatin loops. Our 
data  concerning  the  distribution  of  topoisomerase  II  in 
chicken mitotic chromosomes (15)  are consistent with this 
model. 
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